CAS: 7310-95-4; 2-Hydroxy-5-Methylisophthalaldehyde

上下游产品

CAS号106-44-5 对甲酚 | CAS号100-97-0 乌洛托品 | CAS号91-04-3 2-羟基-5-甲基间苯二甲醇 | CAS号50-00-0 甲醛 | CAS号76107-45-4 5-methyl-2-tosy... | CAS号71128-83-1 2-METHOXY-5-MET... | CAS号6327-85-1 [3-(hydroxymeth... | CAS号68-12-2 N,N-二甲基甲酰胺 | CAS号174504-82-6 6-[(2-hydroxyet... | CAS号113790-38-8 3-(dimethoxymet... | CAS号114485-95-9 3-methyl-5-[(4-... | CAS号71128-83-1 2-METHOXY-5-MET... | CAS号73729-07-4 S-(2,6-diformyl... | CAS号77347-19-4 Methanone,1,1'-...

📜5-Methyl-2-Tosyl-Isophthalaldehyde置于硫酸体系中,化学反应 1.0H,以95 G的收率获得产物2,6-二甲酰-4-甲基苯酚
参考文献:Hydrogenolysis Of Glycerol Using Fe-Fe/al2O3 Complex Catalyst
标题:Hydrogenolysis Of Glycerol Using Fe-Fe/al2O3 Complex Catalyst
摘要:合成了大环络合物催化剂 Fe-Fel1 复合物 L1 (l1 = C24H26O2N4.),并在高压间歇反应器中对甘油反应的氢解反应进行了研究.对催化剂进行了傅立叶变换红外光谱(ftir),X 射线衍射(xrd),热重分析(tga)和 Bet 表面积等表征.氢解研究发现,在 220 oc 温度和 0.35 Mpa 压力下,在氢气和 Fe-Fe/al2O3 的存在下,1,2-丙二醇的选择性为 80%,甘油在水中的浓度为 30%,在 220 oc 温度下,1,2-丙二醇是唯一的产物,转化率为 36%.进一步观察发现,如果水中甘油的浓度超过 40%,总转化率就会下降,并且在反应过程中会产生焦炭状的碳.
DOI:10.14233/ajchem.2016.19950

专利信息

专利号:US-7723539-B2
优先权日:2004-06-16
标题:Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid
发明人：CARLONI SILVIA; BORZATTA VALERIO; MORONI LENI; TANZI GIADA; SARTORI GIOVANNI; MAGGI RAIMONDO
权利人:ENDURA SPA
摘要:Catalysts are described based on metal complexes derived from optically active s compounds, chosen from the classes consisting of bisoxazolines and salicylaldimines supported on an organic or inorganic matrix and employed in particular for the synthesis of optically active chrysanthemic acid.

专利号:US-2009111737-A1
优先权日:1999-05-24
标题:Novel antibacterial agents
发明人：CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
权利人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
摘要:This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to a an enzyme involved in cell wall biosynthesis and metabolism, a precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands hasn a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, pencillinase enzyme, cephalosporinase enzyme, a transglycoslase enzyme, or a transglycosylase enzyme substrate; Preferably, the ligands are selected from the beta lactam or glycopeptide class of antibacterial agents.

专利号:US-2025082601-A1
优先权日:2023-09-08
标题:Significantly non-toxic novel Cobalt(III) Schiff base complex induces apoptosis via G2-M cell cycle arrest in human breast cancer cell line MCF-7 and cell cycle arrest of colon cancer cell lines HCT-116 and SW- 480 via G0-G1
发明人：DASGUPTA SANCHARI; KAR KANISHA PAL; BARUA ATISH; GHOSH DIYA; KABI BIKASH; DEWAN KOUSHIK; CHANDRA ARPITA; BHAR SUNANDITA; DAS TANIMA
权利人:CHITTARANJAN NAT CANCER INSTITUTE
摘要:A significantly non-toxic novel mononuclear cobalt(III)-Schiff base complex (1) capable to induce apoptosis via G2-M cell cycle arrest in human breast cancer cell line MCF-7 and cell cycle arrest of colon cancer cell lines HCT-116 and SW-480 via G0-G1. The Schiff base complex (1) having >99% purity has been synthesized by a facile “One potâ€? synthesis method and has been characterized with standard spectroscopic techniques. Complex 1 exhibits cytotoxicity (IC50=16.81±1.33 μM) at much lower concentration in comparison to oxaliplatin (IC50=31.4±0.69 μM) against MCF-7 cells and causes apoptosis in colon cancer cell lines HCT-116 and SW-480 by arresting the cell cycle at the G0-G1 phase having IC50 values of 15.27±1.18 μM and 10.04±1.98 μM respectively comparable with the IC50 values of oxaliplatin which are 16.73±1.78 μM and 7.87±1.54 μM respectively after 24 h of treatment without being overly toxic to human PBMCs (IC50=>60 μM). In vivo subacute toxicity (28 days) and systemic chronic toxicity (40 days) studies were carried out in normal Swiss albino mice showed 1 is sinificantly nontoxic to the host.

专利号:US-2008021237-A1
优先权日:2004-06-16
标题:Catalysts Based on Metal Complexes for the Synthesis of Optically Active Chrysanthemic Acid

专利号:US-6803471-B2
优先权日:2000-05-31
标 题 :Indolinospiropyran compounds and methods for their manufacture
发明人：CARREIRA ERICK M; ZHAO WEILI
权利人:JOHNSON & JOHNSON VISION CARE
摘要:The present invention provides indolinospiropyran compounds and methods for their manufacture, which compounds are useful as photochromic compounds. The compounds of the invention are substituted on the indole ring with succinimide, which substitution permits ring opening of the succinimide and modulation of the bulk and photochromic properties of the compounds. The compounds may be conveniently prepared using the solid phase organic synthesis of the invention.

专利号:WO-2005123254-A1
优先权日:2004-06-16
标 题:Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid